1 LR applies as follows:

1. (1)

   all of LR (other than LR 8.3, LR 8.4, LR 8.6 and LR 8.7) applies to an issuer; and

2. (2)

   LR 1, LR 8.1, LR 8.3, LR 8.4, LR 8.6 and LR 8.7 apply to a sponsor and a person applying for approval as a sponsor.

FSA performing functions as competent authority

Note: In relation to the listing rules, the FSA is performing functions as the competent authority under Part VI of the Act (see section 72(1) of the Act).

Note: when exercising its functions as the competent authority under Part VI of the Act, the FSA may use the name: the UK Listing Authority.

Other relevant parts of Handbook

Note: Other parts of the Handbook that may also be relevant to issuers or sponsors include DTR (the Disclosure Rules and Transparency Rules sourcebook), PR (the Prospectus Rules sourcebook), COB (the Conduct of Business sourcebook), DEC (the Decision Making manual), Chapter 9 of SUP (the Supervision manual) and Chapter 21 of ENF (the Enforcement manual) and GEN (General Provisions).

1. (1)

   The FSA may dispense with or modify the listing rules in such cases and by reference to such circumstances as it considers appropriate (subject to the terms of EU directives and the Act).

2. (2)

   A dispensation or modification may be either unconditional or subject to specified conditions.

3. (3)

   If an issuer or sponsor has applied for, or been granted, a dispensation or modification, it must notify the FSA immediately it becomes aware of any matter which is material to the relevance or appropriateness of the dispensation or modification.

4. (4)

   The FSA may revoke or modify a dispensation or modification.

1. (1)

   An application to the FSA to dispense with or modify a listing rule must be in writing.

2. (2)

   The application must:

   1. (a)

      contain a clear explanation of why the dispensation or modification is requested;

   2. (b)

      include details of any special requirements, for example, the date by which the dispensation or modification is required;

   3. (c)

      contain all relevant information that should reasonably be brought to the FSA's attention;

   4. (d)

      contain any statement or information that is required by the listing rules to be included for a specific type of dispensation or modification; and

   5. (e)

      include copies of all documents relevant to the application.

An issuer must provide to the FSA as soon as possible:

1. (1)

   any information and explanations that the FSA may reasonably require to decide whether to grant an application for admission;

2. (2)

   any information that the FSA considers appropriate to protect investors or ensure the smooth operation of the market; and [Note: Article 16.1 CARD]

3. (3)

   any other information or explanation that the FSA may reasonably require to verify whether listing rules are being and have been complied with.

1. (1)

   The FSA may, at any time, require an issuer to publish such information in such form and within such time limits as it considers appropriate to protect investors or to ensure the smooth operation of the market. [Note: Article 16.2 CARD]

2. (2)

   If an issuer fails to comply with a requirement under paragraph (1) the FSA may itself publish the information (after giving the issuer an opportunity to make representations as to why it should not be published). [Note: Article 16.2 CARD]

An issuer must take reasonable care to ensure that any information it notifies to a RIS or makes available through the FSA is not misleading, false or deceptive and does not omit anything likely to affect the import of the information.

If an issuer is required to notify information to a RIS at a time when a RIS is not open for business it must distribute the information as soon as possible to:

1. (1)

   not less than two national newspapers in the United Kingdom;

2. (2)

   two newswire services operating in the United Kingdom; and

3. (3)

   a RIS for release as soon as it opens.

1. (1)

   If it appears to the FSA that there is, or there may be, a breach of the listing rules by an issuer with a primary listing, the FSA may in writing require the issuer to appoint a sponsor to advise the issuer on the application of the listing rules.

2. (2)

   If required to do so under paragraph (1), an issuer must, as soon as practicable, appoint a sponsor to advise it on the application of the listing rules.

Note: LR 8.2 sets out the various circumstances in which an issuer must appoint, or obtain guidance from, a sponsor.

If a listing rule refers to a requirement in legislation applicable to a listed company incorporated in the United Kingdom, a listed overseas company must comply with the requirement so far as:

1. (1)

   information available to it enables it to do so; and

2. (2)

   compliance is not contrary to the law in its country of incorporation.

A listed overseas company must, if required to do so by the FSA, provide the FSA with a letter from an independent legal adviser explaining why compliance with a requirement referred to in LR 1.4.2 R is contrary to the law in its country of incorporation.

An issuer whose securities are listed on an overseas investment exchange operating in a non-EEA state, must notify to a RIS information equivalent to that notified to the market of the non-EEA state if the information may be of importance to evaluate the securitieslisted by the FSA. [Note: Articles 69 and 82 CARD]

A document that is required under a listing rule to be filed, notified to a RIS, provided to the FSA or sent to security holders must be in English.

Pursuant to section 118A(5) of the Act, behaviour conforming with the listing rules specified in LR 1 Annex 1 RR does not amount to market abuse under section 118(1) of the Act.

If an issuer makes use of LR 1.4.9 G, it must make the documents available during normal business hours to security holders for a period of not less than 21 days from the date of communication or notification or, if later, until the conclusion of any general meeting to which the documents relate, in printed form and free of charge in sufficient numbers to satisfy demand from security holders at:

1. (1)

   the issuer's registered office in the United Kingdom (if any); and

2. (2)

   the offices of any paying agent of the issuer in the United Kingdom.